ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 225 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2014. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $407,000 | +92.9% | 41,467 | +135.8% | 0.04% | +375.0% |
| Q2 2018 | $211,000 | -51.5% | 17,588 | -50.1% | 0.01% | -50.0% |
| Q1 2018 | $435,000 | -54.9% | 35,247 | -46.9% | 0.02% | -56.8% |
| Q4 2017 | $965,000 | -53.0% | 66,355 | -54.0% | 0.04% | -51.3% |
| Q3 2017 | $2,053,000 | +63.6% | 144,259 | +46.0% | 0.08% | +52.0% |
| Q2 2016 | $1,255,000 | -18.3% | 98,836 | -15.1% | 0.05% | -18.0% |
| Q1 2016 | $1,537,000 | +255.8% | 116,388 | +314.8% | 0.06% | +258.8% |
| Q4 2015 | $432,000 | -37.1% | 28,060 | -49.4% | 0.02% | -46.9% |
| Q3 2015 | $687,000 | -69.4% | 55,409 | -66.9% | 0.03% | -52.9% |
| Q3 2014 | $2,248,000 | +40.2% | 167,537 | +67.7% | 0.07% | +58.1% |
| Q2 2014 | $1,603,000 | +213.7% | 99,881 | +190.6% | 0.04% | +186.7% |
| Q3 2013 | $511,000 | -79.7% | 34,365 | -82.3% | 0.02% | -82.1% |
| Q2 2013 | $2,519,000 | – | 194,648 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |